TA

Thomas D. Aicher

LY Lycera: 8 patents #1 of 21Top 5%
Merck: 2 patents #171 of 961Top 20%
Overall (2019): #12,471 of 560,194Top 3%
8
Patents 2019

Issued Patents 2019

Patent #TitleCo-InventorsDate
10442798 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Clarke B. Taylor, Chad A. VanHuis 2019-10-15
10421751 Dihydro-2H-benzo[b][1,4]oxazine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Clarke B. Taylor, Chad A. VanHuis 2019-09-24
10392350 N-substituted pyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof Donald J. Skalitzky, Clarke B. Taylor 2019-08-27
10377768 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Kenneth J. Barr, Blair T. Lapointe, Vladimir Simov, Karin Ann Stein, William D. Thomas +3 more 2019-08-13
10364237 Tetrahydroquinoline sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Clarke B. Taylor, Chad A. VanHuis 2019-07-30
10221146 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more 2019-03-05
10208061 Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORγ and the treatment of disease Peter L. Toogood, Xiao Hu 2019-02-19
10189777 Benzenesulfonamido and related compounds for use as agonists of RORγ and the treatment of disease Donald J. Skalitzky, Clarke B. Taylor, Chad A. Van Huis 2019-01-29